<DOC>
	<DOC>NCT02111460</DOC>
	<brief_summary>This is a randomized parallel control trial to evaluate whether radical loco-regional Radiotherapy can prolong survival time of initial untreated metastatic nasopharyngeal carcinoma.</brief_summary>
	<brief_title>Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>The patients with initial untreated metastatic nasopharyngeal carcinoma Histologic diagnosis of nasopharyngeal carcinoma T14N03M1,IVC(according to the 7th AJCC edition) Aged between 18 and 65 years KPS≥70 The therapeutic effect evaluation is CR or PR accomplished three course of cisplatin and 5Fu Voluntary to participate and sign informed consent document The patients suffered from serious neurologic disease Clinically significant cardiac, heart function less than or equal to 3 level Clinically significant respiratory disease,lung function less than or equal to 3 level Blood routine examination: WBC＜3×109/L, Hemoglobin＜90g/L, platelet count＜75×109/L Abnormal liver function: total bilirubin or ALT or AST＞2×ULN Abnormal renal function:serum creatinine＞1.5×ULN Pregnant or lactating women The therapeutic effect evaluation is SD or PD accomplished three course of cisplatin and 5Fu</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Initially</keyword>
	<keyword>Untreated</keyword>
	<keyword>Distant metastatic</keyword>
</DOC>